Insider trades
Christopher M. Jewell, Chief Officer of Cartesian Therapeutics RNAC, has filed 0 purchases and 5 sales on the open market. The latest trade was on 25/01/10.
Christopher M. Jewell
Chief Scientific Officer
- Company
- Cartesian Therapeutics RNAC
- First filing
- 23/11/15
- Trades
- 20 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 25/01/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RNAC | Open-market sale | 25/01/03–25/01/06 | 25/01/07 | 2,550 sh2 trades | $16.78avg. | $42,777.46 | −4.6% |
RNAC | Open-market sale | 24/11/14–24/11/15 | 24/11/18 | 52,115 sh3 trades | $16.79avg. | $875,025.9 | −66.8% |